Concordance Between the Multidisciplinary Team and ChatGPT-4o Decisions: A Blinded, Cross-Sectional Concordance Study in Systemic Autoimmune Rheumatic Diseases
Firdevs Ulutaş, Göksel Altınışık, Gülay Güngör, Vefa Çakmak, Nilüfer Yiğit, Duygu Herek, Murat Yiğit, Uğur Karasu, Veli Çobankara · 2025
Read Concordance Between the Multidisciplinary Team and ChatGPT-4o Decisions: A Blinded, Cross-Sectional Concordance Study in Systemic Autoimmune Rheumatic Diseases by Firdevs Ulutaş, Göksel Altınışık, Gülay Güngör, Vefa Çakmak, Nilüfer Yiğit, Duygu Herek, Murat Yiğit, Uğur Karasu, Veli Çobankara (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785839.txt.
Description
Firdevs Ulutaş and co-authors compare a chatbot's care plans with a specialist team's in a 2025 study. Their patients have systemic autoimmune rheumatic diseases, illnesses where the immune system attacks joints, lungs, and other tissues. Care calls are made by a multidisciplinary team of rheumatology, lung, and imaging experts. The team asked how closely ChatGPT-4o would match those calls when blinded to them.
Forty-seven patients with recent team decisions were included. The model answered six set questions per patient, from likely diagnosis to whether drug-free follow-up was safe. Agreement was firm across all decision types on a standard kappa scale. Rheumatoid arthritis was the most common diagnosis in the group. The authors present the match as a sign that AI plans can mirror team thinking in this field, within one test session.
Catalog record
| CREATOR | Firdevs Ulutaş, Göksel Altınışık, Gülay Güngör, Vefa Çakmak, Nilüfer Yiğit, Duygu Herek, Murat Yiğit, Uğur Karasu, Veli Çobankara |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |